Disclosures for "POWER1 – A Double-blind, Randomized, Multicenter Phase 2/3 Study Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Onset Seizures "
-
Dr. steidle has received personal compensation for serving as an employee of Praxis Precision Medicines.
-
Dr. Hansen has received personal compensation for serving as an employee of Praxis Precision Medicines.
-
Dr. Frizzo has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Frizzo has stock in Praxis Precision Medicines.
-
Henry Jacotin has received personal compensation for serving as an employee of Praxis Precision Medicines. Henry Jacotin has stock in Praxis Precision Medicines. Henry Jacotin has stock in Clover Health. Henry Jacotin has stock in Certara. Henry Jacotin has stock in Takeda. Henry Jacotin has received personal compensation in the range of $500,000-$999,999 for serving as a VP Clinical Development and Pharmacovigilance with Praxis Precision Medicines.
-
Mr. Patel has received personal compensation for serving as an employee of Praxis Precision Medicines, Inc..
-
Dr. Epstein has received personal compensation for serving as an employee of Praxis Precision Medicines.
-
Dr. Sun has nothing to disclose.
-
Dr. Petrou has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Petrou has stock in Praxis Precision Medicines. The institution of Dr. Petrou has received research support from Praxis Precision Medicines. Dr. Petrou has received intellectual property interests from a discovery or technology relating to health care.
-
Marcio Souza has received personal compensation for serving as an employee of Praxis Precision Medicines.